Pipeline

Phase 2a + OLE completed (NCT05074498, NCT05476783)

‍ ‍

Phase 2a ongoing (NCT06773962)

IIT placebo-controlled ongoing (NCT06500637)

‍ ‍IND approved (NCT05156827)

‍ ‍Clinical IIT Initiated 

Phase 2a Ready